Biotech Stocks Take A Beating, But Find Support
at Investor's Business Daily - Wed Dec 24, 5:24PM CST
Biotech stocks took a bath in this holiday-shortened week. The catalyst was the announcement by Express Scripts (ESRX), the nation's largest benefits manager, to use AbbVie's (ABBV) hepatitis C drug exclusively. That hurt Gilead Sciences (GILD),...
CBPO: 64.79 (-0.59), ODFL: 79.34 (+0.71), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), AMGN: 160.67 (+3.15), ABBV: 66.21 (+1.86), CELG: 109.60 (+3.48)
US stocks eke out gains in abbreviated trading day
By ALEX VEIGA - AP - Wed Dec 24, 3:23PM CST
Major U.S. stock indexes ended mostly higher on Wednesday, with the Dow Jones industrial average adding modestly to its gains a day after closing above 18,000 for the first time.
ESRX: 85.48 (-0.40), WFC: 55.34 (-0.13), CVX: 113.47 (-0.48), WAG: 76.67 (+0.16)
Could Express Scripts Holding Company's Gilead Gamble Backfire?
Sean Williams, The Motley Fool - Motley Fool - Wed Dec 24, 12:03PM CST
Source: CVS Health. In case you missed it, the hepatitis C community was turned on its head this past weekend with the approval of a new hepatitis C compound and a major move by a pharmacy-benefits manager to strike a long-term deal with that...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), CVS: 97.89 (+0.02), ABBV: 66.21 (+1.86), WAG: 76.67 (+0.16)
First Week Of August 2015 Options Trading For Express Scripts Holding
at The Street - Wed Dec 24, 12:01PM CST
Investors in Express Scripts Holding Co saw new options become available this week, for the August 2015 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until...
ESRX: 85.48 (-0.40)
Stocks Score Small Gains; Virgin America Takes Flight
at Investor's Business Daily - Wed Dec 24, 10:57AM CST
Stocks were filled with Christmas cheer with a little more than one hour remaining in Wednesday's shortened session. The Dow Jones industrial average and the S&P 500 were trading at all-time highs. The Nasdaq led the charge, up 0.4%. The S&P 500 and...
ESRX: 85.48 (-0.40), V: 267.63 (+2.37), VA: 41.00 (+5.19), GILD: 91.29 (+1.84), BAC: 17.98 (+0.05), SN: 9.91 (-0.71), ABBV: 66.21 (+1.86), CELG: 109.60 (+3.48)
What Happened To Gilead Is Health Reform In Action
Dana Blankenhorn - at Seeking Alpha - Wed Dec 24, 10:40AM CST
ESRX: 85.48 (-0.40)
Today's Market: Buying Biotech, Tech And Shipping News
Matthew Smith - at Seeking Alpha - Wed Dec 24, 9:19AM CST
NFLX: 342.10 (+5.67), FDX: 176.42 (-0.52), AMZN: 303.03 (-3.26), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), DTV: 86.82 (-0.05), SNE: 21.32 (+0.46), DIS: 94.42 (-0.27), AAPL: 112.01 (-0.53), UPS: 112.41 (-0.04)
Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers
Peter F. Way, CFA - Seeking Alpha - Wed Dec 24, 8:33AM CST
This is a market price forecast analysis It is not an analysis of medical technology, competition, or economics. We have limited competence in those areas. But we do have extensive experience in how market professionals have interpreted the likely...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), FBT: 100.93 (+1.47), BIB: 122.51 (+3.83), XBI: 182.62 (+3.44), IBB: 299.80 (+5.12), BBH: 113.91 (+1.89), ABBV: 66.21 (+1.86)
Jim Cramer's Picks for What to Buy in Oil and Biotech Into 2015
at The Street - Wed Dec 24, 7:45AM CST
Here's the best way to play oil and biotech.
CI: 104.23 (-0.08), ESRX: 85.48 (-0.40), RDS.A: 68.42 (-0.31), ISIS: 59.49 (+1.88), COG: 30.21 (-0.39), UNH: 102.68 (-0.17), EOG: 94.05 (-2.36), SLB: 87.06 (-0.26), EPD: 35.45 (+0.25), CELG: 109.60 (+3.48)
Why I Expect The Biotech Sell-Off To Continue Into 2015
Sammy Pollack - at Seeking Alpha - Wed Dec 24, 7:08AM CST
BIIB: 340.89 (+5.13), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), IBB: 299.80 (+5.12), AMGN: 160.67 (+3.15), REGN: 400.12 (+6.07), CELG: 109.60 (+3.48)
Gilead Feels The Heat Of Competition
Brendan O'Boyle - at Seeking Alpha - Wed Dec 24, 6:59AM CST
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86)
Express Scripts Sees Heavy Call Volume as Bulls Clean Up
at The Street - Wed Dec 24, 4:30AM CST
Express Scripts has been a monster, and bullish option traders cleaned up quick Tuesday.
ESRX: 85.48 (-0.40)
Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 3:50PM CST
Pharmacy benefit manager Express Scripts (ESRX) announced an update to its National Preferred Formulary, which will now include AbbVie's (ABBV) recently approved new medication for hepatitis C, Viekira Pak.
JNJ: 104.59 (+0.31), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86), CRL: 63.59 (+0.33)
AbbVie Puts The Hurt On Gilead Sciences, Closes Exclusive Deal With Express Scripts
Kal Telage - at Seeking Alpha - Tue Dec 23, 3:41PM CST
JNJ: 104.59 (+0.31), ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86)
Dow Reaches Record Close as Santa Claus Rally Hits Day 5
at The Street - Tue Dec 23, 3:04PM CST
The Dow Jones Industrial Average breaks through 18,000 on Tuesday as third-quarter GDP shows signs of better-than-expected economic health.
PSX: 72.10 (-0.46), HTZ: 24.38 (-0.09), GMCR: 137.65 (+1.10), OCN: 14.88 (-0.14), XOM: 93.78 (-0.81), NQ: 4.32 (-0.36), XLV: 68.64 (+0.50), AGO: 26.28 (+0.23), ESRX: 85.48 (-0.40), RDN: 16.78 (+0.18), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), ABBV: 66.21 (+1.86), CVX: 113.47 (-0.48), SWN: 28.46 (-0.46), WAG: 76.67 (+0.16), REGN: 400.12 (+6.07), XLE: 80.13 (-0.59)
Why Achillion Pharmaceuticals Shares Collapsed by 25% Today
Todd Campbell, The Motley Fool - Motley Fool - Tue Dec 23, 2:03PM CST
Source: Achillion Pharmaceuticals What's happening? Shares of Achillion Pharmaceuticals are crashing 25% today after the company reported mixed early stage drug trial results yesterday and following Express Scripts ' decision to remove ...
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), ABBV: 66.21 (+1.86)
Investors Should Stay Long Stocks as Market Continues Hitting Highs
at The Street - Tue Dec 23, 2:01PM CST
The CNBC 'Fast Money Halftime' trading panel knows there could be some risks in 2015.
AMZN: 303.03 (-3.26), IBB: 299.80 (+5.12), ALSN: 33.94 (+0.05), BAC: 17.98 (+0.05), TLT: 123.95 (+0.41), GOOG: 528.77 (-1.82), ESRX: 85.48 (-0.40), SPY: 207.77 (+0.02), QQQ: 104.30 (+0.09), GILD: 91.29 (+1.84), DIA: 180.03 (unch), APA: 64.05 (-1.38), ABBV: 66.21 (+1.86), BP: 38.95 (-0.17), GOOGL: 536.93 (-1.84), IWM: 119.76 (-0.10), XLE: 80.13 (-0.59)
Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations
at The Street - Tue Dec 23, 1:25PM CST
The Dow Jones Industrial Average breaks through 18,000 on Tuesday as third-quarter GDP shows signs of better-than-expected economic health.
GPRO: 66.41 (+4.87), GMCR: 137.65 (+1.10), OCN: 14.88 (-0.14), NQ: 4.32 (-0.36), XLV: 68.64 (+0.50), AGO: 26.28 (+0.23), ESRX: 85.48 (-0.40), RDN: 16.78 (+0.18), GILD: 91.29 (+1.84), ACHN: 13.06 (+1.22), CHK: 19.84 (-0.45), ABBV: 66.21 (+1.86), SWN: 28.46 (-0.46), WAG: 76.67 (+0.16), REGN: 400.12 (+6.07)
Gilead Sciences Plunges for Second Day In A Row: What Wall Street's Saying
at The Street - Tue Dec 23, 12:48PM CST
The biotech stock's shares fell again Tuesday following the news of Express Scripts' exclusive deal with AbbVie. Here's what analysts said about Gilead.
ESRX: 85.48 (-0.40), GILD: 91.29 (+1.84), ABBV: 66.21 (+1.86)
Express Scripts (ESRX) On Momo Momentum Watch Today
at The Street - Tue Dec 23, 11:24AM CST
Trade-Ideas LLC identified Express Scripts (ESRX) as a momo momentum candidate
ESRX: 85.48 (-0.40)